TRT(SH:600085) Di Yi Cai Jing Zi Xun·2025-12-26 06:18Core Viewpoint - The recent controversy surrounding Tongrentang's krill oil fraud has led to significant management changes and regulatory scrutiny, highlighting issues in brand management and product quality oversight [2][5]. Group 1: Company Actions - On December 25, Tongrentang Group announced that it has taken over the management of Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd., resulting in the dismissal of its general manager and suspension of other related personnel [2]. - Tongrentang has initiated a brand management campaign, conducting thorough checks across its affiliated units and stores, with over 520 inspections completed by December 24 [3]. - The company has launched a product information query system on its official website, providing access to over 1,000 product details to guide consumers in identifying genuine Tongrentang products [3]. Group 2: Regulatory Response - The State Administration for Market Regulation (SAMR) has indicated that the krill oil incident reveals non-compliance in the production and processing practices of companies, leading to plans for new regulations on food production supervision [5]. - SAMR will enhance monitoring of similar brand licensing and processing practices, with upcoming special inspections targeting krill oil and fish oil products to combat illegal activities [5]. Group 3: Legal and Consumer Rights Issues - Legal experts have pointed out that Tongrentang's failure to act against unauthorized use of its trademark after the expiration of its licensing agreement constitutes negligence, potentially infringing on consumer rights [5]. - Consumers remain unaware of the trademark licensing status, which raises concerns about misleading practices that violate their right to information [5].